[Familial combined hyperlipidemia].
Familial combined hyperlipidemia is a common inherited disorder characterized by a hepatic overproduction of apo B particles and an elevated risk for the development of atherosclerosis. LDL particles are smaller and denser and are more prone to oxidation. The exact pathogenesis of familial combined hyperlipidemia is unclear at present. Treatment should aim to reduce the synthesis of atherogenic lipoproteins and to increase the clearance of triglyceride-rich lipoproteins.
Martin
G
G
U325 INSERM, Département d'Athérosclérose, Institut Pasteur, Lille.
Shviro
I
I
Staels
B
B
Auwerx
J
J
D001055:Apolipoproteins B / Q000097:blood; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000235:genetics / Q000378:metabolism / Q000628:therapy
D001055:Apolipoproteins B